{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:19:58Z","timestamp":1793337598949,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100011619","name":"Society for Immunotherapy of Cancer","doi-asserted-by":"publisher","award":["SITC-AstraZeneca Immunotherapy in Lung Cancer Clinical Fellowship"],"award-info":[{"award-number":["SITC-AstraZeneca Immunotherapy in Lung Cancer Clinical Fellowship"]}],"id":[{"id":"10.13039\/100011619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012639","name":"METAvivor","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012639","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP2AI177915"],"award-info":[{"award-number":["DP2AI177915"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s10585-023-10261-3","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T11:03:03Z","timestamp":1707130983000},"page":"351-359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Interrogating the roles of lymph node metastasis in systemic immune surveillance"],"prefix":"10.1007","volume":"41","author":[{"given":"Pamela A.","family":"Basto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan E.","family":"Reticker-Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,5]]},"reference":[{"issue":"6","key":"10261_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nrclinonc.2011.68","volume":"8","author":"L Hutchinson","year":"2011","unstructured":"Hutchinson L, Kirk R (2011) New paradigms to explain metastasis. Nat Rev Clin Oncol 8(6):313. https:\/\/doi.org\/10.1038\/nrclinonc.2011.68","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10261_CR2","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC, Vonderheide RH, Pittet MJ, Jain RK, Zou W, Howcroft TK, Woodhouse EC, Weinberg RA, Krummel MF (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24(5):541\u2013550. https:\/\/doi.org\/10.1038\/s41591-018-0014-x","journal-title":"Nat Med"},{"issue":"6","key":"10261_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41568-023-00568-4","volume":"23","author":"JD Hebert","year":"2023","unstructured":"Hebert JD, Neal JW, Winslow MM (2023) Dissecting metastasis using preclinical models and methods. Nat Rev Cancer 23(6):391\u2013407. https:\/\/doi.org\/10.1038\/s41568-023-00568-4","journal-title":"Nat Rev Cancer"},{"key":"10261_CR4","unstructured":"Amin MBE, S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR (2017) AJCC Cancer Staging Manual, 8th edn. Springer: American Joint Commission on Cancer"},{"issue":"11","key":"10261_CR5","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/nri1222","volume":"3","author":"UH von Andrian","year":"2003","unstructured":"von Andrian UH, Mempel TR (2003) Homing and cellular traffic in lymph nodes. Nat Rev Immunol 3(11):867\u2013878. https:\/\/doi.org\/10.1038\/nri1222","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10261_CR6","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41579-022-00763-4","volume":"20","author":"P Chandra","year":"2022","unstructured":"Chandra P, Grigsby SJ, Philips JA (2022) Immune evasion and provocation by Mycobacterium tuberculosis. Nat Rev Microbiol 20(12):750\u2013766. https:\/\/doi.org\/10.1038\/s41579-022-00763-4","journal-title":"Nat Rev Microbiol"},{"issue":"8","key":"10261_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008632","volume":"16","author":"SKC Ganchua","year":"2020","unstructured":"Ganchua SKC, White AG, Klein EC, Flynn JL (2020) Lymph nodes\u2014the neglected battlefield in tuberculosis. PLoS Pathog 16(8):e1008632. https:\/\/doi.org\/10.1371\/journal.ppat.1008632","journal-title":"PLoS Pathog"},{"issue":"3","key":"10261_CR8","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nrc3186","volume":"12","author":"MA Swartz","year":"2012","unstructured":"Swartz MA, Lund AW (2012) Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity. Nat Rev Cancer 12(3):210\u2013219. https:\/\/doi.org\/10.1038\/nrc3186","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10261_CR9","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41590-023-01443-y","volume":"24","author":"MM Steele","year":"2023","unstructured":"Steele MM, Jaiswal A, Delclaux I, Dryg ID, Murugan D, Femel J, Son S, du Bois H, Hill C, Leachman SA, Chang YH, Coussens LM, Anandasabapathy N, Lund AW (2023) T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control. Nat Immunol 24(4):664\u2013675. https:\/\/doi.org\/10.1038\/s41590-023-01443-y","journal-title":"Nat Immunol"},{"issue":"1","key":"10261_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s10585-021-10123-w","volume":"39","author":"SP Leong","year":"2022","unstructured":"Leong SP, Pissas A, Scarato M, Gallon F, Pissas MH, Amore M, Wu M, Faries MB, Lund AW (2022) The lymphatic system and sentinel lymph nodes: conduit for cancer metastasis. Clin Exp Metastasis 39(1):139\u2013157. https:\/\/doi.org\/10.1007\/s10585-021-10123-w","journal-title":"Clin Exp Metastasis"},{"issue":"7860","key":"10261_CR11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-021-03549-5","volume":"593","author":"MB Buechler","year":"2021","unstructured":"Buechler MB, Pradhan RN, Krishnamurty AT, Cox C, Calviello AK, Wang AW, Yang YA, Tam L, Caothien R, Roose-Girma M, Modrusan Z, Arron JR, Bourgon R, Muller S, Turley SJ (2021) Cross-tissue organization of the fibroblast lineage. Nature 593(7860):575\u2013579. https:\/\/doi.org\/10.1038\/s41586-021-03549-5","journal-title":"Nature"},{"issue":"63","key":"10261_CR12","doi-asserted-by":"publisher","first-page":"eabg3551","DOI":"10.1126\/sciimmunol.abg3551","volume":"6","author":"H du Bois","year":"2021","unstructured":"du Bois H, Heim TA, Lund AW (2021) Tumor-draining lymph nodes: At the crossroads of metastasis and immunity. Sci Immunol 6(63):eabg3551. https:\/\/doi.org\/10.1126\/sciimmunol.abg3551","journal-title":"Sci Immunol"},{"key":"10261_CR13","doi-asserted-by":"publisher","DOI":"10.1101\/2023.05.04.539153","author":"CS McGinnis","year":"2023","unstructured":"McGinnis CS, Miao Z, Reticker-Flynn NE, Winker J, Satpathy AT (2023) The temporal progression of immune remodeling during metastasis. bioRxiv. https:\/\/doi.org\/10.1101\/2023.05.04.539153","journal-title":"bioRxiv"},{"key":"10261_CR14","first-page":"61","volume":"25","author":"W Halsted","year":"1907","unstructured":"Halsted W (1907) The results of radical operations for the cure of cancer of the breast. Trans Am Surg Assoc 25:61\u201379","journal-title":"Trans Am Surg Assoc"},{"issue":"6382","key":"10261_CR15","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1126\/science.aal3622","volume":"359","author":"ER Pereira","year":"2018","unstructured":"Pereira ER, Kedrin D, Seano G, Gautier O, Meijer EFJ, Jones D, Chin SM, Kitahara S, Bouta EM, Chang J, Beech E, Jeong HS, Carroll MC, Taghian AG, Padera TP (2018) Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. Science 359(6382):1403\u20137. https:\/\/doi.org\/10.1126\/science.aal3622","journal-title":"Science"},{"issue":"6382","key":"10261_CR16","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1126\/science.aal3662","volume":"359","author":"M Brown","year":"2018","unstructured":"Brown M, Assen FP, Leithner A, Abe J, Schachner H, Asfour G, Bago-Horvath Z, Stein JV, Uhrin P, Sixt M, Kerjaschki D (2018) Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice. Science 359(6382):1408\u20131411. https:\/\/doi.org\/10.1126\/science.aal3662","journal-title":"Science"},{"issue":"7","key":"10261_CR17","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41588-020-0633-2","volume":"52","author":"JG Reiter","year":"2020","unstructured":"Reiter JG, Hung WT, Lee IH, Nagpal S, Giunta P, Degner S, Liu G, Wassenaar ECE, Jeck WR, Taylor MS, Farahani AA, Marble HD, Knott S, Kranenburg O, Lennerz JK, Naxerova K (2020) Lymph node metastases develop through a wider evolutionary bottleneck than distant metastases. Nat Genet 52(7):692\u2013700. https:\/\/doi.org\/10.1038\/s41588-020-0633-2","journal-title":"Nat Genet"},{"issue":"11","key":"10261_CR18","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.cell.2022.04.019","volume":"185","author":"NE Reticker-Flynn","year":"2022","unstructured":"Reticker-Flynn NE, Zhang W, Belk JA, Basto PA, Escalante NK, Pilarowski GOW, Bejnood A, Martins MM, Kenkel JA, Linde IL, Bagchi S, Yuan R, Chang S, Spitzer MH, Carmi Y, Cheng J, Tolentino LL, Choi O, Wu N, Kong CS, Gentles AJ, Sunwoo JB, Satpathy AT, Plevritis SK, Engleman EG (2022) Lymph node colonization induces tumor-immune tolerance to promote distant metastasis. Cell 185(11):1924\u20131942. https:\/\/doi.org\/10.1016\/j.cell.2022.04.019","journal-title":"Cell"},{"key":"10261_CR19","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.3389\/fimmu.2019.02876","volume":"10","author":"NC DeVito","year":"2019","unstructured":"DeVito NC, Plebanek MP, Theivanthiran B, Hanks BA (2019) Role of tumor-mediated dendritic cell tolerization in immune evasion. Front Immunol 10:2876. https:\/\/doi.org\/10.3389\/fimmu.2019.02876","journal-title":"Front Immunol"},{"issue":"2","key":"10261_CR20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1172\/JCI21583","volume":"114","author":"DH Munn","year":"2004","unstructured":"Munn DH, Sharma MD, Hou D, Baban B, Lee JR, Antonia SJ, Messina JL, Chandler P, Koni PA, Mellor AL (2004) Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest 114(2):280\u2013290. https:\/\/doi.org\/10.1172\/JCI21583","journal-title":"J Clin Invest"},{"issue":"3","key":"10261_CR21","first-page":"483","volume":"3","author":"DI Gabrilovich","year":"1997","unstructured":"Gabrilovich DI, Corak J, Ciernik IF, Kavanaugh D, Carbone DP (1997) Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res 3(3):483\u2013490","journal-title":"Clin Cancer Res"},{"key":"10261_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.molimm.2018.03.025","volume":"113","author":"J Bandola-Simon","year":"2019","unstructured":"Bandola-Simon J, Roche PA (2019) Dysfunction of antigen processing and presentation by dendritic cells in cancer. Mol Immunol 113:31\u201337. https:\/\/doi.org\/10.1016\/j.molimm.2018.03.025","journal-title":"Mol Immunol"},{"issue":"3","key":"10261_CR23","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cell.2019.02.005","volume":"177","author":"M Binnewies","year":"2019","unstructured":"Binnewies M, Mujal AM, Pollack JL, Combes AJ, Hardison EA, Barry KC, Tsui J, Ruhland MK, Kersten K, Abushawish MA, Spasic M, Giurintano JP, Chan V, Daud AI, Ha P, Ye CJ, Roberts EW, Krummel MF (2019) Unleashing type-2 dendritic cells to drive protective antitumor CD4(+) T cell immunity. Cell 177(3):556\u201371. https:\/\/doi.org\/10.1016\/j.cell.2019.02.005","journal-title":"Cell"},{"issue":"5\u20136","key":"10261_CR24","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1159\/000337007","volume":"4","author":"EE Gray","year":"2012","unstructured":"Gray EE, Cyster JG (2012) Lymph node macrophages. J Innate Immun 4(5\u20136):424\u2013436. https:\/\/doi.org\/10.1159\/000337007","journal-title":"J Innate Immun"},{"issue":"9","key":"10261_CR25","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/cas.12212","volume":"104","author":"K Ohnishi","year":"2013","unstructured":"Ohnishi K, Komohara Y, Saito Y, Miyamoto Y, Watanabe M, Baba H, Takeya M (2013) CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma. Cancer Sci 104(9):1237\u20131244. https:\/\/doi.org\/10.1111\/cas.12212","journal-title":"Cancer Sci"},{"issue":"2","key":"10261_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108993","volume":"35","author":"C Tacconi","year":"2021","unstructured":"Tacconi C, Commerford CD, Dieterich LC, Schwager S, He Y, Ikenberg K, Friebel E, Becher B, Tugues S, Detmar M (2021) CD169(+) lymph node macrophages have protective functions in mouse breast cancer metastasis. Cell Rep 35(2):108993. https:\/\/doi.org\/10.1016\/j.celrep.2021.108993","journal-title":"Cell Rep"},{"issue":"8","key":"10261_CR27","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1002\/ijc.34172","volume":"151","author":"Y Qian","year":"2022","unstructured":"Qian Y, Zhai E, Chen S, Liu Y, Ma Y, Chen J, Liu J, Qin C, Cao Q, Chen J, Cai S (2022) Single-cell RNA-seq dissecting heterogeneity of tumor cells and comprehensive dynamics in tumor microenvironment during lymph nodes metastasis in gastric cancer. Int J Cancer 151(8):1367\u20131381. https:\/\/doi.org\/10.1002\/ijc.34172","journal-title":"Int J Cancer"},{"issue":"16","key":"10261_CR28","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1158\/1078-0432.CCR-10-1073","volume":"16","author":"L Deng","year":"2010","unstructured":"Deng L, Zhang H, Luan Y, Zhang J, Xing Q, Dong S, Wu X, Liu M, Wang S (2010) Accumulation of foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients. Clin Cancer Res 16(16):4105\u20134112. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-1073","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10261_CR29","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1038\/s41467-020-17046-2","volume":"11","author":"NG Nunez","year":"2020","unstructured":"Nunez NG, Tosello Boari J, Ramos RN, Richer W, Cagnard N, Anderfuhren CD, Niborski LL, Bigot J, Meseure D, De La Rochere P, Milder M, Viel S, Loirat D, Perol L, Vincent-Salomon A, Sastre-Garau X, Burkhard B, Sedlik C, Lantz O, Amigorena S, Piaggio E (2020) Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients. Nat Commun 11(1):3272. https:\/\/doi.org\/10.1038\/s41467-020-17046-2","journal-title":"Nat Commun"},{"issue":"8","key":"10261_CR30","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ccell.2022.06.009","volume":"40","author":"A van Krimpen","year":"2022","unstructured":"van Krimpen A, Gerretsen VIV, Mulder E, van Gulijk M, van den Bosch TPP, von der Thusen J, Grunhagen DJ, Verhoef C, Mustafa D, Aerts JG, Stadhouders R, Dammeijer F (2022) Immune suppression in the tumor-draining lymph node corresponds with distant disease recurrence in patients with melanoma. Cancer Cell 40(8):798\u2013799. https:\/\/doi.org\/10.1016\/j.ccell.2022.06.009","journal-title":"Cancer Cell"},{"issue":"6","key":"10261_CR31","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cell.2023.02.021","volume":"186","author":"MK Rahim","year":"2023","unstructured":"Rahim MK, Okholm TLH, Jones KB, McCarthy EE, Liu CC, Yee JL, Tamaki SJ, Marquez DM, Tenvooren I, Wai K, Cheung A, Davidson BR, Johri V, Samad B, O\u2019Gorman WE, Krummel MF, van Zante A, Combes AJ, Angelo M, Fong L, Algazi AP, Ha P, Spitzer MH (2023) Dynamic CD8(+) T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes. Cell 186(6):1127\u20131143. https:\/\/doi.org\/10.1016\/j.cell.2023.02.021","journal-title":"Cell"},{"issue":"1","key":"10261_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1146\/annurev-cancerbio-030518-055653","volume":"3","author":"JS Miller","year":"2019","unstructured":"Miller JS, Lanier LL (2019) Natural killer cells in cancer immunotherapy. Annu Rev Cancer Biol 3(1):77\u2013103. https:\/\/doi.org\/10.1146\/annurev-cancerbio-030518-055653","journal-title":"Annu Rev Cancer Biol"},{"key":"10261_CR33","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.1038\/ncomms6639","volume":"5","author":"TH Ali","year":"2014","unstructured":"Ali TH, Pisanti S, Ciaglia E, Mortarini R, Anichini A, Garofalo C, Tallerico R, Santinami M, Gulletta E, Ietto C, Galgani M, Matarese G, Bifulco M, Ferrone S, Colucci F, Moretta A, Karre K, Carbone E (2014) Enrichment of CD56(dim)KIR + CD57 + highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients. Nat Commun 5:5639. https:\/\/doi.org\/10.1038\/ncomms6639","journal-title":"Nat Commun"},{"issue":"3","key":"10261_CR34","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/SLA.0000000000005028","volume":"277","author":"E Gottlieb-Vedi","year":"2023","unstructured":"Gottlieb-Vedi E, Kauppila JH, Mattsson F, Hedberg J, Johansson J, Edholm D, Lagergren P, Nilsson M, Lagergren J, group F (2023) Extent of lymphadenectomy and long-term survival in esophageal cancer. Ann Surg 277(3):429\u201336. https:\/\/doi.org\/10.1097\/SLA.0000000000005028","journal-title":"Ann Surg"},{"key":"10261_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-023-10336-y","author":"N van der Wielen","year":"2023","unstructured":"van der Wielen N, Daams F, Rosati R, Parise P, Weitz J, Reissfelder C, Del Val ID, Loureiro C, Parada-Gonzalez P, Pintos-Martinez E, Vallejo FM, Achirica CM, Sanchez-Pernaute A, Campos AR, Bonavina L, Asti ELG, Poza AA, Gilsanz C, Nilsson M, Lindblad M, Gisbertz SS, van Berge Henegouwen MI, Romario UF, De Pascale S, Akhtar K, Cuesta MA, van der Peet DL, Straatman J (2023) Correction: three-year survival and distribution of lymph node metastases in gastric cancer following neoadjuvant chemotherapy: results from a European randomized clinical trial. Surg Endosc. https:\/\/doi.org\/10.1007\/s00464-023-10336-y","journal-title":"Surg Endosc"},{"issue":"14","key":"10261_CR36","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.3390\/cancers15143735","volume":"15","author":"B Manfredini","year":"2023","unstructured":"Manfredini B, Zirafa CC, Filosso PL, Stefani A, Romano G, Davini F, Melfi F (2023) The role of lymphadenectomy in early-stage NSCLC. Cancers 15(14):3735. https:\/\/doi.org\/10.3390\/cancers15143735","journal-title":"Cancers"},{"key":"10261_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2023.04.001","author":"NE Reticker-Flynn","year":"2023","unstructured":"Reticker-Flynn NE, Engleman EG (2023) Lymph nodes: at the intersection of cancer treatment and progression. Trends Cell Biol. https:\/\/doi.org\/10.1016\/j.tcb.2023.04.001","journal-title":"Trends Cell Biol"},{"issue":"3","key":"10261_CR38","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.cell.2016.12.022","volume":"168","author":"MH Spitzer","year":"2017","unstructured":"Spitzer MH, Carmi Y, Reticker-Flynn NE, Kwek SS, Madhireddy D, Martins MM, Gherardini PF, Prestwood TR, Chabon J, Bendall SC, Fong L, Nolan GP, Engleman EG (2017) Systemic immunity is required for effective cancer immunotherapy. Cell 168(3):487\u2013502. https:\/\/doi.org\/10.1016\/j.cell.2016.12.022","journal-title":"Cell"},{"issue":"8","key":"10261_CR39","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","volume":"25","author":"KE Yost","year":"2019","unstructured":"Yost KE, Satpathy AT, Wells DK, Qi Y, Wang C, Kageyama R, McNamara KL, Granja JM, Sarin KY, Brown RA, Gupta RK, Curtis C, Bucktrout SL, Davis MM, Chang ALS, Chang HY (2019) Clonal replacement of tumor-specific T cells following PD-1 blockade. Nat Med 25(8):1251\u20131259. https:\/\/doi.org\/10.1038\/s41591-019-0522-3","journal-title":"Nat Med"},{"issue":"23","key":"10261_CR40","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124507","volume":"3","author":"MF Fransen","year":"2018","unstructured":"Fransen MF, Schoonderwoerd M, Knopf P, Camps MG, Hawinkels LJ, Kneilling M, van Hall T, Ossendorp F (2018) Tumor-draining lymph nodes are pivotal in PD-1\/PD-L1 checkpoint therapy. JCI Insight 3(23):124507. https:\/\/doi.org\/10.1172\/jci.insight.124507","journal-title":"JCI Insight"},{"issue":"5","key":"10261_CR41","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ccell.2020.09.001","volume":"38","author":"F Dammeijer","year":"2020","unstructured":"Dammeijer F, van Gulijk M, Mulder EE, Lukkes M, Klaase L, van den Bosch T, van Nimwegen M, Lau SP, Latupeirissa K, Schetters S, van Kooyk Y, Boon L, Moyaart A, Mueller YM, Katsikis PD, Eggermont AM, Vroman H, Stadhouders R, Hendriks RW, Thusen JV, Grunhagen DJ, Verhoef C, van Hall T, Aerts JG (2020) The PD-1\/PD-L1-checkpoint restrains T cell immunity in tumor-draining lymph nodes. Cancer Cell 38(5):685\u2013700. https:\/\/doi.org\/10.1016\/j.ccell.2020.09.001","journal-title":"Cancer Cell"},{"issue":"1","key":"10261_CR42","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.1038\/s41467-022-31941-w","volume":"13","author":"R Saddawi-Konefka","year":"2022","unstructured":"Saddawi-Konefka R, O\u2019Farrell A, Faraji F, Clubb L, Allevato MM, Jensen SM, Yung BS, Wang Z, Wu VH, Anang NA, Msari RA, Schokrpur S, Pietryga IF, Molinolo AA, Mesirov JP, Simon AB, Fox BA, Bui JD, Sharabi A, Cohen EEW, Califano JA, Gutkind JS (2022) Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC. Nat Commun 13(1):4298. https:\/\/doi.org\/10.1038\/s41467-022-31941-w","journal-title":"Nat Commun"},{"issue":"1","key":"10261_CR43","doi-asserted-by":"publisher","first-page":"7015","DOI":"10.1038\/s41467-022-34676-w","volume":"13","author":"LB Darragh","year":"2022","unstructured":"Darragh LB, Gadwa J, Pham TT, Van Court B, Neupert B, Olimpo NA, Nguyen K, Nguyen D, Knitz MW, Hoen M, Corbo S, Joshi M, Zhuang Y, Amann M, Wang XJ, Dow S, Kedl RM, Samedi V, Boss MK, Karam SD (2022) Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors. Nat Commun 13(1):7015. https:\/\/doi.org\/10.1038\/s41467-022-34676-w","journal-title":"Nat Commun"},{"issue":"25","key":"10261_CR44","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","volume":"386","author":"A Cercek","year":"2022","unstructured":"Cercek A, Lumish M, Sinopoli J, Weiss J, Shia J, Lamendola-Essel M, El Dika IH, Segal N, Shcherba M, Sugarman R, Stadler Z, Yaeger R, Smith JJ, Rousseau B, Argiles G, Patel M, Desai A, Saltz LB, Widmar M, Iyer K, Zhang J, Gianino N, Crane C, Romesser PB, Pappou EP, Paty P, Garcia-Aguilar J, Gonen M, Gollub M, Weiser MR, Schalper KA, Diaz LA Jr (2022) PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer. N Engl J Med 386(25):2363\u20132376. https:\/\/doi.org\/10.1056\/NEJMoa2201445","journal-title":"N Engl J Med"},{"issue":"4","key":"10261_CR45","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41591-020-0829-0","volume":"26","author":"JM Versluis","year":"2020","unstructured":"Versluis JM, Long GV, Blank CU (2020) Learning from clinical trials of neoadjuvant checkpoint blockade. Nat Med 26(4):475\u2013484. https:\/\/doi.org\/10.1038\/s41591-020-0829-0","journal-title":"Nat Med"},{"issue":"9","key":"10261_CR46","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1056\/NEJMoa2211437","volume":"388","author":"SP Patel","year":"2023","unstructured":"Patel SP, Othus M, Chen Y, Wright GP Jr, Yost KJ, Hyngstrom JR, Hu-Lieskovan S, Lao CD, Fecher LA, Truong TG, Eisenstein JL, Chandra S, Sosman JA, Kendra KL, Wu RC, Devoe CE, Deutsch GB, Hegde A, Khalil M, Mangla A, Reese AM, Ross MI, Poklepovic AS, Phan GQ, Onitilo AA, Yasar DG, Powers BC, Doolittle GC, In GK, Kokot N, Gibney GT, Atkins MB, Shaheen M, Warneke JA, Ikeguchi A, Najera JE, Chmielowski B, Crompton JG, Floyd JD, Hsueh E, Margolin KA, Chow WA, Grossmann KF, Dietrich E, Prieto VG, Lowe MC, Buchbinder EI, Kirkwood JM, Korde L, Moon J, Sharon E, Sondak VK, Ribas A (2023) Neoadjuvant-adjuvant or adjuvant-only pembrolizumab in advanced melanoma. N Engl J Med 388(9):813\u2013823. https:\/\/doi.org\/10.1056\/NEJMoa2211437","journal-title":"N Engl J Med"},{"issue":"7791","key":"10261_CR47","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","volume":"577","author":"BA Helmink","year":"2020","unstructured":"Helmink BA, Reddy SM, Gao J, Zhang S, Basar R, Thakur R, Yizhak K, Sade-Feldman M, Blando J, Han G, Gopalakrishnan V, Xi Y, Zhao H, Amaria RN, Tawbi HA, Cogdill AP, Liu W, LeBleu VS, Kugeratski FG, Patel S, Davies MA, Hwu P, Lee JE, Gershenwald JE, Lucci A, Arora R, Woodman S, Keung EZ, Gaudreau PO, Reuben A, Spencer CN, Burton EM, Haydu LE, Lazar AJ, Zapassodi R, Hudgens CW, Ledesma DA, Ong S, Bailey M, Warren S, Rao D, Krijgsman O, Rozeman EA, Peeper D, Blank CU, Schumacher TN, Butterfield LH, Zelazowska MA, McBride KM, Kalluri R, Allison J, Petitprez F, Fridman WH, Sautes-Fridman C, Hacohen N, Rezvani K, Sharma P, Tetzlaff MT, Wang L, Wargo JA (2020) B cells and tertiary lymphoid structures promote immunotherapy response. Nature 577(7791):549\u2013555. https:\/\/doi.org\/10.1038\/s41586-019-1922-8","journal-title":"Nature"},{"issue":"3","key":"10261_CR48","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","volume":"55","author":"M Meylan","year":"2022","unstructured":"Meylan M, Petitprez F, Becht E, Bougouin A, Pupier G, Calvez A, Giglioli I, Verkarre V, Lacroix G, Verneau J, Sun CM, Laurent-Puig P, Vano YA, Elaidi R, Mejean A, Sanchez-Salas R, Barret E, Cathelineau X, Oudard S, Reynaud CA, de Reynies A, Sautes-Fridman C, Fridman WH (2022) Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer. Immunity 55(3):527\u2013541. https:\/\/doi.org\/10.1016\/j.immuni.2022.02.001","journal-title":"Immunity"},{"key":"10261_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.978069","volume":"12","author":"H Xia","year":"2022","unstructured":"Xia H, Zhang W, Zhang Y, Shang X, Liu Y, Wang X (2022) Liver metastases and the efficacy of immune checkpoint inhibitors in advanced lung cancer: a systematic review and meta-analysis. Front Oncol 12:978069. https:\/\/doi.org\/10.3389\/fonc.2022.978069","journal-title":"Front Oncol"},{"issue":"1","key":"10261_CR50","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","volume":"27","author":"J Yu","year":"2021","unstructured":"Yu J, Green MD, Li S, Sun Y, Journey SN, Choi JE, Rizvi SM, Qin A, Waninger JJ, Lang X, Chopra Z, El Naqa I, Zhou J, Bian Y, Jiang L, Tezel A, Skvarce J, Achar RK, Sitto M, Rosen BS, Su F, Narayanan SP, Cao X, Wei S, Szeliga W, Vatan L, Mayo C, Morgan MA, Schonewolf CA, Cuneo K, Kryczek I, Ma VT, Lao CD, Lawrence TS, Ramnath N, Wen F, Chinnaiyan AM, Cieslik M, Alva A, Zou W (2021) Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination. Nat Med. 27(1):152\u201364. https:\/\/doi.org\/10.1038\/s41591-020-1131-x","journal-title":"Nat Med."},{"issue":"52","key":"10261_CR51","doi-asserted-by":"publisher","first-page":"aba0759","DOI":"10.1126\/sciimmunol.aba0759","volume":"5","author":"JC Lee","year":"2020","unstructured":"Lee JC, Mehdizadeh S, Smith J, Young A, Mufazalov IA, Mowery CT, Daud A, Bluestone JA (2020) Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis. Sci Immunol 5(52):aba0759. https:\/\/doi.org\/10.1126\/sciimmunol.aba0759","journal-title":"Sci Immunol"},{"issue":"3","key":"10261_CR52","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.celrep.2012.01.005","volume":"1","author":"AW Lund","year":"2012","unstructured":"Lund AW, Duraes FV, Hirosue S, Raghavan VR, Nembrini C, Thomas SN, Issa A, Hugues S, Swartz MA (2012) VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics. Cell Rep 1(3):191\u2013199. https:\/\/doi.org\/10.1016\/j.celrep.2012.01.005","journal-title":"Cell Rep"},{"issue":"9","key":"10261_CR53","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1172\/JCI79434","volume":"126","author":"AW Lund","year":"2016","unstructured":"Lund AW, Wagner M, Fankhauser M, Steinskog ES, Broggi MA, Spranger S, Gajewski TF, Alitalo K, Eikesdal HP, Wiig H, Swartz MA (2016) Lymphatic vessels regulate immune microenvironments in human and murine melanoma. J Clin Invest 126(9):3389\u20133402. https:\/\/doi.org\/10.1172\/JCI79434","journal-title":"J Clin Invest"},{"issue":"1","key":"10261_CR54","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41467-020-14906-9","volume":"11","author":"X Yu","year":"2020","unstructured":"Yu X, Dai Y, Zhao Y, Qi S, Liu L, Lu L, Luo Q, Zhang Z (2020) Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response. Nat Commun 11(1):1110. https:\/\/doi.org\/10.1038\/s41467-020-14906-9","journal-title":"Nat Commun"},{"key":"10261_CR55","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.addr.2020.07.023","volume":"161\u2013162","author":"AJ Najibi","year":"2020","unstructured":"Najibi AJ, Mooney DJ (2020) Cell and tissue engineering in lymph nodes for cancer immunotherapy. Adv Drug Deliv Rev 161\u2013162:42\u201362. https:\/\/doi.org\/10.1016\/j.addr.2020.07.023","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"10261_CR56","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1200\/JCO.2017.77.3994","volume":"36","author":"MGM Roemer","year":"2018","unstructured":"Roemer MGM, Redd RA, Cader FZ, Pak CJ, Abdelrahman S, Ouyang J, Sasse S, Younes A, Fanale M, Santoro A, Zinzani PL, Timmerman J, Collins GP, Ramchandren R, Cohen JB, De Boer JP, Kuruvilla J, Savage KJ, Trneny M, Ansell S, Kato K, Farsaci B, Sumbul A, Armand P, Neuberg DS, Pinkus GS, Ligon AH, Rodig SJ, Shipp MA (2018) Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic hodgkin lymphoma. J Clin Oncol 36(10):942\u2013950. https:\/\/doi.org\/10.1200\/JCO.2017.77.3994","journal-title":"J Clin Oncol"},{"issue":"1","key":"10261_CR57","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1159\/000512828","volume":"14","author":"M Zhou","year":"2021","unstructured":"Zhou M, Bui N, Lohman M, van de Rjin M, Hwang G, Ganjoo K (2021) Long-term remission with ipilimumab\/nivolumab in two patients with different soft tissue sarcoma subtypes and no PD-L1 expression. Case Rep Oncol 14(1):459\u2013465. https:\/\/doi.org\/10.1159\/000512828","journal-title":"Case Rep Oncol"},{"issue":"1","key":"10261_CR58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s42047-019-0033-z","volume":"2","author":"AM Alves","year":"2019","unstructured":"Alves AM, Paredes J, Schmitt F (2019) Expression of PD-L1 in primary breast carcinoma and lymph node metastases. Surg Exp Pathol 2(1):7. https:\/\/doi.org\/10.1186\/s42047-019-0033-z","journal-title":"Surg Exp Pathol"},{"key":"10261_CR59","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001558","author":"M Rozenblit","year":"2020","unstructured":"Rozenblit M, Huang R, Danziger N, Hegde P, Alexander B, Ramkissoon S, Blenman K, Ross JS, Rimm DL, Pusztai L (2020) Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2020-001558","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10261_CR60","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12885-017-3916-y","volume":"18","author":"M Li","year":"2018","unstructured":"Li M, Li A, Zhou S, Xu Y, Xiao Y, Bi R, Yang W (2018) Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer. BMC Cancer 18(1):4. https:\/\/doi.org\/10.1186\/s12885-017-3916-y","journal-title":"BMC Cancer"},{"issue":"26","key":"10261_CR61","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2006684","volume":"382","author":"P Schmid","year":"2020","unstructured":"Schmid P, Dent R, O\u2019Shaughnessy J (2020) Pembrolizumab for early triple-negative breast cancer. Reply N Engl J Med 382(26):e108. https:\/\/doi.org\/10.1056\/NEJMc2006684","journal-title":"Reply N Engl J Med"},{"issue":"2","key":"10261_CR62","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1200\/JCO.22.00686","volume":"41","author":"T Andre","year":"2023","unstructured":"Andre T, Tougeron D, Piessen G, de la Fouchardiere C, Louvet C, Adenis A, Jary M, Tournigand C, Aparicio T, Desrame J, Lievre A, Garcia-Larnicol ML, Pudlarz T, Cohen R, Memmi S, Vernerey D, Henriques J, Lefevre JH, Svrcek M (2023) Neoadjuvant nivolumab plus ipilimumab and adjuvant nivolumab in localized deficient mismatch repair\/microsatellite instability-high gastric or esophagogastric junction adenocarcinoma: the GERCOR NEONIPIGA phase II study. J Clin Oncol 41(2):255\u2013265. https:\/\/doi.org\/10.1200\/JCO.22.00686","journal-title":"J Clin Oncol"},{"key":"10261_CR63","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2302983","author":"H Wakelee","year":"2023","unstructured":"Wakelee H, Liberman M, Kato T, Tsuboi M, Lee SH, Gao S, Chen KN, Dooms C, Majem M, Eigendorff E, Martinengo GL, Bylicki O, Rodriguez-Abreu D, Chaft JE, Novello S, Yang J, Keller SM, Samkari A, Spicer JD, Investigators K (2023) Perioperative pembrolizumab for early-stage non-small-cell lung cancer. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2302983","journal-title":"N Engl J Med"},{"issue":"6","key":"10261_CR64","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1056\/NEJMoa2215530","volume":"389","author":"M Provencio","year":"2023","unstructured":"Provencio M, Nadal E, Gonz\u00e1lez-Larriba JL, Mart\u00ednez-Mart\u00ed A, Bernab\u00e9 R, Bosch-Barrera J, Casal-Rubio J, Calvo V, Insa A, Ponce S, Reguart N, de Castro J, Mosquera J, Cobo M, Aguilar A, L\u00f3pez Vivanco G, Camps C, L\u00f3pez-Castro R, Mor\u00e1n T, Barneto I, Rodr\u00edguez-Abreu D, Serna-Blasco R, Ben\u00edtez R, de la Aguado Rosa C, Palmero R, Hernando-Trancho F, Mart\u00edn-L\u00f3pez J, Cruz-Berm\u00fadez A, Massuti B, Romero A (2023) Perioperative nivolumab and chemotherapy in stage III non-small-cell lung cancer. N Engl J Med 389(6):504\u201313. https:\/\/doi.org\/10.1056\/NEJMoa2215530","journal-title":"N Engl J Med"},{"issue":"17","key":"10261_CR65","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJMoa2209813","volume":"387","author":"ND Gross","year":"2022","unstructured":"Gross ND, Miller DM, Khushalani NI, Divi V, Ruiz ES, Lipson EJ, Meier F, Su YB, Swiecicki PL, Atlas J, Geiger JL, Hauschild A, Choe JH, Hughes BGM, Schadendorf D, Patel VA, Homsi J, Taube JM, Lim AM, Ferrarotto R, Kaufman HL, Seebach F, Lowy I, Yoo SY, Mathias M, Fenech K, Han H, Fury MG, Rischin D (2022) Neoadjuvant cemiplimab for stage II to IV cutaneous squamous-cell carcinoma. N Engl J Med 387(17):1557\u20131568. https:\/\/doi.org\/10.1056\/NEJMoa2209813","journal-title":"N Engl J Med"},{"issue":"3","key":"10261_CR66","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41591-018-0337-7","volume":"25","author":"TF Cloughesy","year":"2019","unstructured":"Cloughesy TF, Mochizuki AY, Orpilla JR, Hugo W, Lee AH, Davidson TB, Wang AC, Ellingson BM, Rytlewski JA, Sanders CM, Kawaguchi ES, Du L, Li G, Yong WH, Gaffey SC, Cohen AL, Mellinghoff IK, Lee EQ, Reardon DA, O\u2019Brien BJ, Butowski NA, Nghiemphu PL, Clarke JL, Arrillaga-Romany IC, Colman H, Kaley TJ, de Groot JF, Liau LM, Wen PY, Prins RM (2019) Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nat Med 25(3):477\u2013486. https:\/\/doi.org\/10.1038\/s41591-018-0337-7","journal-title":"Nat Med"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-023-10261-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-023-10261-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-023-10261-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T15:14:31Z","timestamp":1725462871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-023-10261-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,5]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["10261"],"URL":"https:\/\/doi.org\/10.1007\/s10585-023-10261-3","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,5]]},"assertion":[{"value":"14 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}